L2 - sources of drugs and their nature Flashcards
briefly describe the drug discovery process (3 steps)
- basic research in labs and universities - better understanding of physiology and diseases
- identification of possible drug targets
- hypothesis generated
what things need to be considered at the start of the drug discovery process?
- safety
- ethics
- does the drug already have patent
- cost effectiveness
why are animal models used in drug development?
to test safety of drugs on body systems similar to humans
what are the sources of drugs
natural - plants
compound libraries
combinational chemistry
give an example of a naturally sourced drug and its use
morphine - opium poppy - analgesia
what is combinatorial chemistry
a way of creating new compounds quickly
reacting molecules with a certain number of attachment points with as many substituents as desired to produce new compounds
how can you work out the number of combinations of molecules from combinational chemistry?
attachment points
substituents ^
eg a molecule with 3 attachment points reacted with 9 substituents would give 9^3 combinations (729)
what is high throughput screening
screens many compounds very quickly to identify potential biological activity
eg if it binds to a certain enzyme
how are structure activity relationships useful in drug development
a drugs structure has profound effects on its activity
a drugs structure can be manipulated (eg groups added) to improve drugs effectiveness
how long is pre clinical stage and what occurs in preclinical stage
5-10 years
everything up to human testing
what is the purpose of phase 1 clinical trials
- check drug safety (dangerous side effects)
2. check drug tolerability (unpleasant side effects)
what has to happen before phase 1 clinical trials
drug toxicity tested in at least 2 mammals
describe process of phase 1 clinical trials
involves a small no. of healthy volunteers exposed to increasing doses of drug
purpose of phase 2 clinical trials
to determine drug effectiveness in patients with illness
what happens in phase 2a
exploratory phase to determine most effective dose